NAN Logo

Home > Skip Navigation LinksConference > Abstracts - 2010 NAN Conference

NAN 2010 Abstract Submission Period - March 1 - May 1, 2010

To access the abstract submittal system:

  1. Please logon to your account on the column to the left. 
  2. Click on Update Profile
  3. Go to the section titled Abstracts in the lower right-hand corner, and click on 2010 NAN Conference to begin the process.

If you do not have a NAN account, click on Set Up Account on the left-hand column to create one, the follow the steps above. 

For step by step instructions, please click here.


INSTRUCTIONS FOR ABSTRACT SUBMISSIONS

  • Section A - Test-Focused Workshops. Instructions for submitting an abstract for a test-focused workshop presentation.
  • Section B - Special Topics Presentations. Instructions for submitting an abstract for a special topics presentation.
  • Section C - Grand Rounds Submissions. Instructions for submitting a structured abstract for Grand Rounds presentation.
  • Section D - Poster Submissions. Instructions for submitting a structured abstract reporting original data from investigations with human subjects. If you plan to submit a case study for poster presentation only (not submitted for Grand Rounds) please use Poster Presentation as your submission type but following the guidelines (including structured abstract formatting) for submitting cases presented in section C.
  • Section E - Poster Submissions. Instructions for submitting a structured abstract reporting information from a theoretical/quantitative review.
  • Section F - How to use the system

Section A - Instructions for Preparing Test-Focused Workshop Submissions.

The Program Committee is soliciting new ideas and presenters through a forum of a two-hour, two CEU, Test-Focused Workshop.   Test publishers are invited to submit a proposal to promote a specific neuropsychological assessment instrument. In this format, test publishers provide presenters at their own expense. The presenter will devote the first half of the workshop to issues of test administration and scoring and the second hour to interpretation of test results with case examples. Test publishers are invited to submit a proposal to be competitively reviewed.   Submissions must include a title for the presentation, a list of presenters/authors, and a 255-word submission. The submission should include the following information: Test Publisher, Publisher Address, and a narrative summary of your proposed workshop.

Section B - Instructions for Preparing Special Topics Presentation Submissions.

The Program Committee is soliciting new ideas and presenters through a forum of a two-hour, no CEU, Special Topic Presentation.   These presentations may be a review of research, a theoretical presentation, clinical issues, or a short workshop. This is NAN's most flexible format. Proposals will be judged on: potential for appealing to the greatest number of attendees, novelty, and quality. Submissions must include a title, list of authors/presenters, and a 255 word narrative summary of your proposed presentation.

Section C - Instructions for Grand Rounds Presentation Submissions.

The Program Committee is soliciting submissions for our popular Grand Rounds forum. Grand Rounds submissions can be made in one of three areas: Adult, Pediatric, Diversity or Forensic (civil and criminal). The Adult, Pediatric, or Forensic Grand Rounds Chair and the Poster Review Committee blind-reviews all submissions. The Grand Rounds Chairperson selects three to four cases for presentation during a two hour, no CEU oral presentation. Submissions not selected for oral presentation will be considered for poster presentation.   Oral presenters will be given approximately 15 minutes to present the case, followed by a discussion/question period led by the Grand Rounds Chair, a distinguished panel of expert discussants (selected by the Chair), and the audience.   In accordance with the guidelines for Case Presentation submissions recently adopted by the Archives of Clinical Neuropsychology, we are particularly interested in cases that add to the literature in the following ways:

  1. Unambiguous presentations of rare conditions or new findings adding to our current understanding of well studied conditions or,
  2. Complicated presentations that clearly demonstrate the role of polyetiologic factors in the development or progression of the condition under study.

All presentations should highlight the relationships between disease processes, neuropsychological, and neuroanatomical findings in a way that sheds new light on our understanding of brain-behavior relationships.

Grand Rounds authors should prepare an abstract of no more than 255 words under the following headings: Objective:, Method:, Results:, and Conclusions:. To permit quick and selective scanning, only the headings outlined above should be included in the abstract. Guidelines for the type of information to be included under each heading are provided below.

Objective: Briefly describe the context of the case or the existing literature in the area of the case and state how the case will expand upon or clarify the existing literature. Method: Describe the Case History (onset and course of symptoms, results of diagnostic tests and procedures, imaging results if relevant, etc.) Results: Present the results of neuropsychological findings. Conclusions: Discuss the findings in light of the introduction and specific purpose of this case's unique or classic findings

Section D - Instructions for Poster Presentation Submissions when Reporting Original Data from Investigations with Human Subjects (for Reviews & Meta-Analyses, see Section E)

Authors should prepare an abstract of no more than 255 words under the following headings: Objective:, Method:, Results:, and Conclusions:. To permit quick and selective scanning, only the headings outlined above should be included in the abstract.  Abstracts without data or in which 'data is to be collected' or 'results are expected to show' cannot be accepted.

  1. Objective. The abstract should begin with a clear statement of the precise objective or question addressed in the report. If more than one objective is addressed, the main objective should be indicated and only key secondary objectives stated. If an a priori hypothesis was tested, it should be stated.
  2. Method. The basic design of the study should be described, including participants/setting and variables/measures. Participants/Setting. The numbers of participants and how they were selected should be provided. The clinical disorders and key socio-demographic features of participants should be stated. Selection procedures, entry criteria, and numbers of participants entering and finishing the study may also be included. To assist readers to determine the applicability of the report to their own clinical circumstances, the study setting(s) may be described. Consider whether the setting is the general community, a primary care or referral center, private or institutional practice, ambulatory or hospitalized care. Variables/Measure(s). Describe the design of the study. The primary study variables and instruments should be clearly explained.
  3. Results. The main results of the study should be given. When possible, the results should be accompanied by confidence intervals (for example, 95%) and the level of statistical significance.
  4. Conclusion(s). Only those conclusions of the study that are directly supported by the evidence reported should be given. Equal emphasis should be given to positive and negative findings of equal scientific merit. If clinical applications are described, avoid speculation and over-generalization and indicate whether additional study is required before the information should be used in usual clinical settings.

Section E - Instructions for Poster Presentation Submissions when Reporting Data from Theoretical/Quantitative Reviews (Including Meta-analyses)

Authors should prepare an abstract of no more than 255 words under the following headings: Objective:, Data Selection:, Data Synthesis:, Conclusions:. To permit quick and selective scanning, the headings outlined above should be included in the abstract.

  1. Objective. The abstract should begin with a precise statement of the primary objective of the review. The focus of this statement should be guided by whether the review emphasizes factors such as cause, diagnosis, prognosis, therapy, or prevention. It should include information about the specific population, intervention or exposure, and test or outcome that is being reviewed.
  2. Data Selection. This section may include data sources, data selection criteria, and data extraction as relevant to the review. If informal procedures were used, this should be stated. Data Sources. Describe the data sources that were searched, including dates, terms, and constraints. Study Selection. Identify the number of studies reviewed and the criteria used for their selection. Data Extraction. Summarize guidelines used for abstracting data and how they were applied.
  3. Data Synthesis. State the main results of the review and the methods used to obtain these results.
  4. Conclusions. The conclusions and their applications should be clearly stated, limiting generalization to the domain of the review. The need for new studies may be suggested.

Section F - How to use the system

For step by step instructions on how to submit an abstract, click here.

 

If you have any questions, please contact the NAN Office at office@nanonline.org, or by calling 303-691-3694.